Insmed
INSM
#856
Rank
A$39.90 B
Marketcap
A$184.87
Share price
-2.25%
Change (1 day)
64.81%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -A$1.83 Billion

According to Insmed's latest financial reports the company's current earnings are A$0.60 Billion. a decrease over its 2024 earnings that were of -A$1.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -A$1.66 Billion43.91%
2024 -A$1.16 Billion23.71%
2023 -A$0.94 Billion45.77%
2022 -A$0.64 Billion15.83%
2021 -A$0.56 Billion50.19%
2020 -A$0.37 Billion16.4%
2019 -A$0.32 Billion-23.9%
2018 -A$0.42 Billion59.35%
2017 -A$0.26 Billion8.52%
2016 -A$0.24 Billion47.25%
2015 -A$0.17 Billion34.53%
2014 -A$0.13 Billion58.83%
2013 -A$76.14 Million35.14%
2012 -A$56.34 Million-31.92%
2011 -A$82.76 Million854.92%
2010 -A$8.67 Million-105.22%
2009 A$0.16 B-905.06%
2008 -A$20.62 Million-27.31%
2007 -A$28.36 Million-62.41%
2006 -A$75.44 Million98.19%
2005 -A$38.06 Million0.03%
2004 -A$38.05 Million159.07%
2003 -A$14.69 Million-69.31%
2002 -A$47.85 Million
2000 -A$43.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.68 B-1,469.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$13.59 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.45 B-489.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.98 Billion-41.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$32.25 Million-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-A$2.62 Million-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA